Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440570
Status:
COMPLETED
Last Update Posted:
2011-06-29
First Post:
2007-02-24
Brief Title:
A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors
Sponsor:
Pasche Boris MD
Organization:
Pasche Boris MD
Study Overview
Official Title:
Treatment of Advanced Cancer With Amplitude-modulated Electromagnetic Fields of Low Intensity by Means of an Intrabuccal Probe
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
THBC001
Brief Summary:
In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth We have identified specific frequencies that may block cancer cell growth We have developed a device delivering low levels of amplitude-modulated electromagnetic fields The device is connected to a spoon-like coupler which is placed in the patients mouth during treatment We will conduct a feasibility study consisting of three daily ambulatory treatments until disease progression
Detailed Description:
Background In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth We have identified specific frequencies that may block cancer cell growth We have developed a portable and programmable device delivering low levels of amplitude-modulated electromagnetic fields The device is connected to a spoon-like coupler which is placed in the patients mouth during treatment
Methods We will conducted a feasibility study consisting of three daily treatments All patients with advanced solid tumors and measurable disease will be eligible irrespective of prior treatments Patients will be assessed with laboratory exams complete blood count comprehensive profile tumor markers imaging studies every other month for the first six months every third month thereafter
Methods We will conducted a feasibility study consisting of three daily treatments All patients with advanced solid tumors and measurable disease will be eligible irrespective of prior treatments Patients will be assessed with laboratory exams complete blood count comprehensive profile tumor markers imaging studies every other month for the first six months every third month thereafter
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None